Skip to content

Comparison of Safety and Efficacy of Ultrasound-guided versus DSA-guided Percutaneous Biliary Drainage in the Treatment of Malignant Biliary Tract Obstruction : A Single-center, Prospective, Randomized Controlled Study

Comparison of Safety and Efficacy of Ultrasound-guided versus DSA-guided Percutaneous Biliary Drainage in the Treatment of Malignant Biliary Tract Obstruction : A Single-center, Prospective, Randomized Controlled Study

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073343
Enrollment
Unknown
Registered
2023-07-07
Start date
2023-05-10
Completion date
Unknown
Last updated
2023-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Biliary Tract Obstruction

Interventions

Control Group:DSA-guided PTBD
Experimental Group:Ultrasound-guided PTBD

Sponsors

Cancer Hospital, Chinese Academy of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: 1. Age = 18 years old and = 85 years old; 2. Malignant obstructive jaundice confirmed by imaging and pathology; 3. Volunteer to participate in the experiment.

Exclusion criteria

Exclusion criteria: 1. Pregnancy; 2. Abnormal coagulation function (INR>1.5 or PLT<50×10^9/L or long-term oral anticoagulants); 3. Complicated with severe cardiopulmonary disease, hematological system disease, and other systemic diseases that cannot tolerate surgery; 4. Concomitant intrahepatic bile duct stones or Mirizzi syndrome; 5. Concomitant with other serious liver diseases, pancreatitis, primary sclerosing cholangitis, or systemic infections, etc 6. A large amount of abdominal fluid accumulation; 7. Previously underwent yellow reduction surgery such as PTBD or EBD.

Design outcomes

Primary

MeasureTime frame
Total incidence of complications;

Secondary

MeasureTime frame
Technical success rate;Clinical success rate;operation duration;number of times of puncture;

Countries

China

Contacts

Public ContactLi Xiao

Cancer Hospital, Chinese Academy of Medical Science

simonlixiao@gmail.com+86 185 1977 0241

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026